In contrast, for the sub-group of patients with a detectable HIV RNA, the HIV RNA level at start of second-line cART led to an increased hazard of failure with borderline significance.
← all excerpts
Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.
1
—
—